{"title":"Prenatal polysubstance exposure alters behaviour in zebrafish larvae","authors":"Lise Hermant , Gabriel D. Bossé","doi":"10.1016/j.pnpbp.2026.111686","DOIUrl":null,"url":null,"abstract":"<div><div>Substance use during pregnancy has been linked to various adverse outcomes in infants, including congenital disabilities, neurodevelopmental delays, and long-term effects such as learning difficulties. An additional concern is that newborns are often exposed to multiple substances in utero. The biological consequences of such exposure remain largely unknown. Zebrafish offer an exciting alternative to fill this gap and deepen our understanding of the biological impact of prenatal multidrug exposure. We utilized zebrafish's scalability to expose embryos to some of the most commonly used substances: nicotine, alcohol, opioids, and all their possible combinations. After embryonic drug exposure, we conducted a detailed behavioural analysis across three developmental stages. Our results revealed drug-specific outcomes, including both synergistic and antagonistic effects. Furthermore, we identified distinctive effects across development, highlighting potential developmental shifts and individual differences in resilience. Overall, these findings demonstrate that prenatal polydrug exposure results in complex, stage-dependent effects, sometimes antagonistic, which cannot be predicted from single-drug outcomes. Our study emphasizes the value of zebrafish as a model for investigating polydrug interactions and provides a framework for exploring biomarkers of vulnerability and resilience in offspring.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"146 ","pages":"Article 111686"},"PeriodicalIF":3.9000,"publicationDate":"2026-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278584626000825","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Substance use during pregnancy has been linked to various adverse outcomes in infants, including congenital disabilities, neurodevelopmental delays, and long-term effects such as learning difficulties. An additional concern is that newborns are often exposed to multiple substances in utero. The biological consequences of such exposure remain largely unknown. Zebrafish offer an exciting alternative to fill this gap and deepen our understanding of the biological impact of prenatal multidrug exposure. We utilized zebrafish's scalability to expose embryos to some of the most commonly used substances: nicotine, alcohol, opioids, and all their possible combinations. After embryonic drug exposure, we conducted a detailed behavioural analysis across three developmental stages. Our results revealed drug-specific outcomes, including both synergistic and antagonistic effects. Furthermore, we identified distinctive effects across development, highlighting potential developmental shifts and individual differences in resilience. Overall, these findings demonstrate that prenatal polydrug exposure results in complex, stage-dependent effects, sometimes antagonistic, which cannot be predicted from single-drug outcomes. Our study emphasizes the value of zebrafish as a model for investigating polydrug interactions and provides a framework for exploring biomarkers of vulnerability and resilience in offspring.
期刊介绍:
Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject.
Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.